Accessibility Menu
 
LeonaBio logo

LeonaBio

(NASDAQ) ATHA

Current PriceN/A
Market CapN/A
Since IPO (2020)-95%
5 Year-95%
1 Year+196%
1 Month-3%

LeonaBio Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$105.61M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About LeonaBio

Industry

Pharmaceuticals

Employees

19

CEO

Mark J. Litton, PhD, MBA

Headquarters

Bothell, WA 98011, US

ATHA Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-3%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$68.09M

Operating Income

$102.27M

EBITDA

$102.27M

Operating Cash Flow

$45.73M

Capital Expenditure

$0.00

Free Cash Flow

$45.73M

Cash & ST Invst.

$88.33M

Total Debt

$803.00K

LeonaBio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$67.40M

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

26

N/A

Net Income

$82.89M

-452.5%

EBITDA

$80.10M

-422.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$87.53M

+74.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$338.00K

-57.9%

Short Term Debt

$465.00K

+12.3%

Return on Assets

-1.15%

N/A

Return on Invested Capital

-2.29%

N/A

Free Cash Flow

$19.40M

+25.4%

Operating Cash Flow

$19.40M

+25.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LPTXLeap Therapeutics, Inc.
$0.77-3.15%
CTXRCitius Pharmaceuticals, Inc.
$0.65-5.92%
ICUSeaStar Medical Holding Corporation
$3.92+2.89%
APLMApollomics, Inc.
$12.85-2.58%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$18.36-0.02%
NOKNokia
$11.30+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$60.74-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.14-0.01%

Questions About ATHA

What is the current price of LeonaBio?

LeonaBio is trading at N/A per share.

What is the 52-week range for LeonaBio?

Over the past 52 weeks, LeonaBio has traded between N/A and N/A.

How much debt does LeonaBio have?

As of the most recent reporting period, LeonaBio reported total debt of $803,000.

How much cash does LeonaBio have on hand?

LeonaBio reported $69.28M in cash and cash equivalents in its most recent financial results.

What is LeonaBio’s dividend yield?

LeonaBio does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.